Literature DB >> 19472221

Proliferation deficits and gene expression dysregulation in Down's syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres.

Randal X Moldrich1, Luce Dauphinot, Julien Laffaire, Tania Vitalis, Yann Hérault, Philip M Beart, Jean Rossier, Denis Vivien, Corinne Gehrig, Stylianos E Antonarakis, Robert Lyle, Marie-Claude Potier.   

Abstract

Down's syndrome neurophenotypes are characterized by mental retardation and a decreased brain volume. To identify whether deficits in proliferation could be responsible for this phenotype, neural progenitor cells were isolated from the developing E14 neocortex of Down's syndrome partial trisomy Ts1Cje mice and euploid (WT) littermates and grown as neurospheres. Ts1Cje neural progenitors proliferated at a slower rate, because of a longer cell cycle, and a greater number of cells were positive for glial fibrillary acidic protein. An increase in cell death was also noted. Gene expression profiles of neural progenitor cells from Ts1Cje and WT showed that 54% of triploid genes had expression ratios (Ts1Cje/WT) significantly greater than the expected diploid gene ratio of 1.0. Some diploid genes associated with proliferation, differentiation, and glial function were dysregulated. Interestingly, proliferation and gene expression dysregulation detected in the Ts1Cje mice did not require overexpression of the chromosome 21 genes amyloid precursor protein (App) and soluble superoxide dismutase 1 (Sod1). (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19472221     DOI: 10.1002/jnr.22131

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  16 in total

1.  DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.

Authors:  Nobuhiro Kurabayashi; Minh Dang Nguyen; Kamon Sanada
Journal:  EMBO Rep       Date:  2015-09-15       Impact factor: 8.807

2.  The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.

Authors:  Faycal Guedj; Jeroen L A Pennings; Millie A Ferres; Leah C Graham; Heather C Wick; Klaus A Miczek; Donna K Slonim; Diana W Bianchi
Journal:  Am J Med Genet A       Date:  2015-05-14       Impact factor: 2.802

3.  Transcriptional consequences of aneuploidy.

Authors:  Jason M Sheltzer; Eduardo M Torres; Maitreya J Dunham; Angelika Amon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 4.  Antioxidants in Down syndrome.

Authors:  Ira T Lott
Journal:  Biochim Biophys Acta       Date:  2011-12-21

5.  Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome.

Authors:  Aarti Ruparelia; Matthew L Pearn; William C Mobley
Journal:  Curr Opin Neurobiol       Date:  2012-05-30       Impact factor: 6.627

6.  Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors.

Authors:  Hiruy S Meharena; Asaf Marco; Vishnu Dileep; Elana R Lockshin; Grace Y Akatsu; James Mullahoo; L Ashley Watson; Tak Ko; Lindsey N Guerin; Fatema Abdurrob; Shruthi Rengarajan; Malvina Papanastasiou; Jacob D Jaffe; Li-Huei Tsai
Journal:  Cell Stem Cell       Date:  2022-01-06       Impact factor: 24.633

7.  Aneuploidy causes tissue-specific qualitative changes in global gene expression patterns in maize.

Authors:  Irina Makarevitch; Carolyn Harris
Journal:  Plant Physiol       Date:  2009-12-11       Impact factor: 8.340

8.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

Review 9.  Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics.

Authors:  Nicole Créau
Journal:  Neural Plast       Date:  2012-07-12       Impact factor: 3.599

10.  Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.

Authors:  Aarti Ruparelia; Frances Wiseman; Olivia Sheppard; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  J Biomed Res       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.